NCT05583591 - Combined Phacoemulsification With iStent Inject W Versus Hydrus for Mild to Moderate Open Angle Glaucoma | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

October 1, 2022

Primary Completion Date

April 22, 2024

Study Completion Date

April 22, 2024

Conditions

Open Angle Glaucoma

Interventions

DEVICE

Combined cataract surgery with Hydrus microstent

Device designed to help lower intraocular pressure by improving aqueous outflow through the trabecular meshwork. Used in combination with cataract surgery.

DEVICE

Combined cataract surgery with iStent Inject W

Device designed to help lower intraocular pressure by improving aqueous outflow through the trabecular meshwork. Used in combination with cataract surgery.

Trial Locations (1)

94598

Diablo Eye Associates, Walnut Creek